1. Myers J, Buchanan N, Walsh D, et al. Comparison of the ramp versus standard exercise protocols. J Am Coll Cardiol 1991; 17: 1334-1342.
2. Stringer WW, Hansen JE, Wasserman K. Cardiac output estimated noninvasively from oxygen uptake during exercise. J Appl Physiol 1997; 82: 908-912.
3. Stringer W, Whipp B, Wasserman K, Christenson P, French W. Non-linear cardiac output dynamics during ramp-incremental cycle ergometry. Eur J Appl Physiol 2005; 93: 634-639.
4. Perego GB, Marenzi M, Guazzi M, et al. Contribution of PO2, P50, and Hb to changes in arteriovenous O2 content during exercise in heart failure. J Appl Physiol 1996; 80: 623-631.
5. Lang C, Katlin P, Haythe J, Tsao L, Mancini D. Ease of non invasive measurements of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure. Am J Cardiol 2007; 99: 404-405.
6. Agostoni PG, Wasserman K, Guazzi M, et al. Exercise-induced hemoconcentration in heart failure due to dilated cardiomyopathy. Am J Cardiol 1999; 83: 278-280.
7. Agostoni P, Cerino M, Palermo P, et al. Exercise capacity in patients with ß-thalassaemia intermedia. Br J Haem 2005; 131: 278-281.
8. Stringer WW, Wasserman K, Casaburi R, et al. Lactic acidosis as a facilitator of oxyhaemoglobin dissociation during exercise. J Appl Physiol 1994; 76: 1462-1467.
9. Agostoni PG, Wasserman K, Perego GB, et al. Oxygen transport to muscle during exercise in chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 1997; 79: 29-33.
10. Wittenberg BA, Wittenberg JB. Transport of oxygen in muscle. Annu Rev Physiol 1989; 51: 857-878.
11. Koike A, Wasserman K, Taniguchi K, Hiroe M, Marumo F. Critical capillary oxygen partial pressure and lactate threshold in patients with cardiovascular disease. J Am Coll Cardiol 1994; 23: 1644-1650.
12. Richardson RS, Knight DR, Poole DC, et al. Determinants of maximal exercise VO2 during single leg knee-extensor exercise in humans. Am J Physiol 1995; 268: H1453-H1461.
13. Agostoni PG, Wasserman K, Perego GB, et al. Non-invasive measurement of stroke volume during exercise in heart failure patients. Clin Sci 2000; 98: 545-551.
14. Elborn JS, Stanford CF, Nicholls DP. Reproducibility of cardiopulmonary parameters during exercise in patients with chronic cardiac failure. The need for a preliminary test. Eur Heart J1990; 11: 75-81.
15. Buchfuhrer MJ, Hansen JE, Robinson TE, Sue DY, Wasserman K, Whipp BJ. Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol 1983; 55: 1558-1564.
16. Agostoni PG, Bianchi M, Moraschi A, et al. Work rate affects cardiopulmonary exercise test results in heart failure. Eur J Heart Fail 2005; 7: 498-504.
17. Koike A, Yajima T, Adachi H, et al. Evaluation of exercise capacity using submaximal exercise at a constant work rate in patients with cardiovascular disease. Circulation 1995; 81: 1719-1724.
18. Belardinelli R, Zhang YY, Wasserman K, Purcaro A, Agostoni PG. A four-minute submaximal constant work rate exercise test to assess cardiovascular functional class in chronic heart failure. Am J Cardiol 1998; 81: 1210-1214.
19. Tanabe Y, Takahashi M, Hosaka Y, Ito M, Ito E, Suzuki H. Prolonged recovery of cardiac output after maximal exercise in patients with chronic heart failure. J Am Coll Cardiol 2000; 35: 1228-1236.
20. Zhang YY, Wasserman K, Sietsema KE, et al. O2 uptake kinetics in response to exercise. A measure of tissue anaerobiosis in heart failure. Chest 1993; 103: 735-741.
21. Sietsema KE, Daly JA, Wasserman K. Early dynamics of O2 uptake and heart rate as affected by exercise work rate. J Appl Physiol 1989; 67: 2535-2541.
22. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
23. Bitter V, Weiner DH, Yusuf S, et al. Predictors of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA 1993; 270: 1702-1707.
24. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests in the cardiorespiratory domain. Chest 2001; 119: 256-270.
25. Zugck C, Kruger C, Durr S, et al. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomiopathy? Eur Heart J 2000; 21: 540-549.
26. Shepard R. Exercise for patients with congestive heart failure. Sports Med 1997; 23: 75-92.
27. Weber KT, Janicki JS. Cardiopulmonary exercise testing for evaluation of chronic cardiac failure. Am J Cardiol 1985; 55: 22A-31A.
28. Stelken AM, Younis LT, Jennison SH, et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 1996; 27: 345-352.
29. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987; 59: 634-638.
30. Aaronson KD, Mancini DM. Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure? J Heart Lung Transplant 1995; 14: 981-989.
31. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334: 1349-1355.
32. Colucci WS, Packer M, Bristow MR, et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation 1996; 94: 2800-2806.
33. Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002; 106: 2194-2199.
34. Lechat P, Hulot JS, Escolano S, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 2001; 103: 1428-1433.
35. Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 1997; 30: 27-34.
36. Sullivan MJ, Cobb FR. The anaerobic threshold in chronic heart failure. Relation to blood lactate, ventilatory basis, reproducibility, and response to exercise training. Circulation 1990; 81: 47-58.
37. Beaver WL, Wasserman K, Whipp BJ. Improved detection of lactate threshold during exercise using a log-log transformation. J Appl Physiol 1985; 59: 1936-1940.
38. Whipp BJ, Ward SA, Wasserman K. Respiratory markers of the anaerobic threshold. Adv Cardiol 1986; 35: 47-64.
39. Whipp BJ. Physiological mechanisms dissociating pulmonary CO2 and O2 exchange dynamics during exercise. Exp Physiol 2007; 92: 347-355.
40. Berardinelli R, Lacalaprice F, Carle F, et al. Exercise-induced myocardial ischemia detected by cardiopulmonary exercise testing. Eur Heart J 2003; 24: 1304-1313.
41. Goerg R, Reinicke H, Daum S. The oxygen pulse coefficient: an index of physical working capacity. Bull Eur Physiopathol Respir 1979; 15: 135-142.
42. Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ. Clinical applications of cardiopulmonary exercise testing. In: Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ, eds. Principle of Exercise Testing and Interpretation. 3rd Edn. Philadelphia, Lippincott Williams, 1999; pp. 77-78.
43. Williams SG, Cooke GA, Wright DJ, et al. Peak exercise cardiac power output. A direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J 2001; 22: 1496-1503.
44. Cotter G, Williams SG, Vered Z, Tan LB. Role of cardiac power in heart failure. Curr Opin Cardiol 2003; 18: 215-222.
45. Franciosa JA, Ziesche S, Wilen M. Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization. Am J Med 1979; 67: 460-466.
46. Weber KT, Kinasewitz GT, Janicki JS, Fishman AF. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation 1982; 65: 1213-1223.
47. Gelber HJ, Rubin SA, Ports TA, Brundage BH, Parmley WW, Chatteree K. Detection of left ventricular functional reserve by supine exercise heamodynamics in patients with severe, chronic heart failure. Am J Cardiol 1979; 44: 1062-1067.
48. Griffin BP, Shah PK, Ferguson J, Rubin SA. Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy. Am J Cardiol 1991; 67: 848-853.
49. Roul G, Moulichon ME, Bareiss P, et al. Prognostic factors of chronic heart failure in NYHA class II or III: value of invasive exercise haemodynamic data. Eur Heart J 1995; 16: 1387-1398.
50. Chomsky DB, Lang CC, Rayos GH, et al. Haemodymanic exercise testing. A valuable tool in the selection of cardiac transplantation candidates. Circulation 1996; 94: 3176-3183.
51. Metra M, Faggiano P, D'Aloia A, et al. Use of cardiopulmonary exercise testing with haemodynamic monitoring in the prognostic assessment of ambulatorial patients with chronic heart failure. J Am Coll Cardiol 1999; 33: 943-950.
52. Myers J, Gullestad L, Vagelos R, et al. Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med 1998; 129: 286-293.
53. Leier CV, Patrick TJ, Hermiller J, et al. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow. Am Heart J 1984; 108: 1461-1468.
54. Lipkin DP, Poole-Wilson PA. Measurement of cardiac output during exercise by the thermodilution and direct Fick techniques in patients with chronic congestive heart failure. Am J Cardiol 1985; 56: 321-324.
55. Nakanishi N, Yoshioka T, Okano Y, Nishimura T. Continuous Fick cardiac output measurement during exercise by monitoring of mixed venous oxygen saturation and oxygen uptake. Chest 1993; 104: 419-426.
56. Elkayam U, Wilson AF, Morrison J, et al. Noninvasive measurement of cardiac output by single breath constant expiratory technique. Thorax 1984; 39: 107-113.
57. Zenger MR, Brenner M, Haruno M, Mahon D, Wilson AF. Measurement of cardiac output by automated single-breath technique, and comparison with thermodilution and Fick methods in patients with cardiac disease. Am J Cardiol 1993; 71: 105-109.
58. Jones NL, Campbell EJM, McHardy GJR, Higgs BE, Clode M. The estimation of carbon dioxide pressure of mixed venous blood during exercise. Clin Sci 1967; 32: 311-327.
59. Van Herwaardem A, Binkhorst RA, Fennis JFM, Laar A. Reliability of the cardiac output measurement. The indirect Fick-principle for CO2 during exercise. Pflugers Arch 1980; 385: 21-23.
60. Klausen K. Comparison of CO2 rebreathing and acetylene methods for cardiac output. J Appl Physiol 1965; 20: 763-766.
61. Farhi LE, Nesarajah MS, Olszowka AJ, Metildi LA, Ellis AK. Cardiac output determination by simple one-step rebreathing technique. Respir Physiol 1976; 28: 141-159.
62. Sramek BB. Thoracic electrical bioimpedance measurement of cardiac output. Crit Care Med 1994; 22: 1337-1339.
63. Stok WJ, Baisch F, Hillebrecht A, Schulz H, Meyer M, Karemaker J. Noninvasive cardiac output measurement by arterial pulse analysis compared with inert gas rebreathing. J Appl Physiol 1993; 74: 2687-2693.
64. Sackner MA, Greeneltch D, Heiman MS, Epstein S, Atkins N. Diffusing capacity, membrane diffusing capacity, capillary blood volume, pulmonary tissue volume, and cardiac output measurement by a rebreathing technique. Am Rev Respir Dis 1975; 111: 157-165.
65. Cohn JN, Johnson GR, Shabetai R, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87: VI5-V16.
66. Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Circulation 1989; 80: 769-781.
67. Agostoni P, Cattadori G, Apostolo A, et al. Noninvasive measurements of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evaluation. Am J Coll Cardiol 2005; 46: 1779-1781.
68. Wasserman K, Zhang Y, Gitt A, et al. Lung function and exercise gas exchange in chronic heart failure. Circulation 1997; 96: 2221-2227.
69. Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 1988; 77: 552-559.
70. Metra M, Dei Cas L, Panina G, Visioli O. Exercise hyperventilation chronic congestive heart failure, and its relation to functional capacity and hemodynamics. Am J Cardiol 1992; 70: 622-628.
71. Lipkin DP, Poole-Wilson PA. Symptoms limiting exercise in chronic heart failure. Br Med J Clin Res 1986; 292: 1030-1031.
72. Myers J, Salleh A, Buchanan N, et al. Ventilatory mechanisms of exercise intolerance in chronic heart failure. Am Heart J 1992; 124: 710-719.
73. Agostoni PG, Marenzi GC, Pepi M, et al. Isolated ultrafiltration for moderate heart failure. J Am Coll Cardiol 1993; 21: 424-431.
74. Agostoni P, Pellegrino R, Conca C, Rodarte J, Brusasco V. Exercise hyperpnea in chronic heart failure: relation to lung stiffness and exercise flow limitation. J Appl Physiol 2002; 92: 1409-1416.
75. Kleber FX, Vietzke G, Wernecke KD, et al. Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 2000; 101: 2803-2809.
76. Ponikowski P, Chua TP, Piepoli M, et al. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 1997; 96: 2586-2594.
77. Chua TP, Clark AL, Amadi AA, Coats AJ. Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1996; 27: 650-657.
78. Chua TP, Harrington D, Ponikowski P, Webb-Peploe K, Poole-Wilson PA, Coats AJ. Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 1997; 29: 147-152.
79. Ponikowski P, Francis DP, Piepoli MF, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001; 103: 967-972.
80. Scott AC, Francis DP, Coats AJS, Piepoli MF. Reproducibility of the measurement of the muscle ergoreflex activity in chronic heart failure. Eur J Heart Fail 2003; 5: 453-461.
81. Wasserman K, Whipp BJ, Koyal SN, Cleary M. Effect of carotid body resection on ventilatory and acid-base control during exercise. J Appl Physiol 1975; 39: 354-358.
82. Johnson BD, Weisman IM, Zeballos RJ, Beck KC. Emerging concepts in the evaluation of ventilatory limitation during exercise. The exercise tidal flow-volume loop. Chest 1999; 116: 488-503.
83. Wilson IR, Ferraro N. Effect of the renin-angiotensin system on limb circulation and metabolism during exercise in patients with chronic heart failure. J Am Coll Cardiol 1985; 6: 556-563.
84. Hamroff G, Katz SD, Mancini D, et al. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Circulation 1999; 99: 990-992.
85. Guazzi M, Marenzi GC, Alimento M, Contini M, Agostoni PG. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation 1997; 95: 1930-1936.
86. Agostoni P, Guazzi M, Bussotti M, De Vita S, Palermo P. Carvedilol reduces the inappropriate increase of ventilation during exercise in heart failure patients. Chest 2002; 122: 2062-2067.
87. Agostoni P, Magini A, Andreini D, et al. Spironolactone improves lung diffusion in chronic heart failure. Eur Heart J 2005; 26: 159-164.
88. Agostoni PG, Marenzi GC, Sganzerla P, et al. Lung-heart interaction as a substrate for the improvement in exercise capacity following body fluid volume depletion in moderate congestive heart failure. Am J Cardiol 1995; 76: 793-798.
89. Agostoni PG, Guazzi M, Bussotti M, Grazi M, Palermo P, Marenzi G. Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure. J Am Coll Cardiol 2000; 36: 1600-1604.
Was this article helpful?